Trial intelligence / Profile preview

Dexmedetomidine added to bupivacaine local infiltration for postoperative pain after pediatric inguinal herniorrhaphy

IRCT2016060314372N8Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
Aug 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of dexmedetomidine and bupivacaine in inguinal hernia (2 arms), sponsored by Shiraz University of Medical Sciences. Started Aug 2016; status: completed.

02

Drugs

dexmedetomidinebupivacaine
03

Conditions

inguinal hernia

Beyond the preview

Go deeper on IRCT2016060314372N8.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016060314372N8.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call